Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2021

01-02-2021 | Septicemia | Original Article

Laboratory and clinical impacts of an overnight laboratory service

Authors: Paul R. Ingram, L. Barrett, E. Raby, P. Boan, G. A. Weaire-Buchanan, H. Darragh, P. Lloyd, I. Kay, J. Flexman

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2021

Login to get access

Abstract

Delayed initiation of effective antimicrobial therapy for sepsis is associated with increased mortality. Whilst automated blood culture machines operate continuously, this does not align with conventional staff working hours and so turn-around-times (TAT) for reporting gram stains to clinicians are 3–7 times longer for blood cultures that flag positive overnight. We retrospectively compared laboratory TATs and clinical outcomes for blood cultures from 183 patients that flagged positive overnight during a 4-month period before and after the implementation of an overnight laboratory service. Enterobacterales and urinary tract infections were the most frequent pathogens and clinical syndrome respectively, and the prevalence of multi-resistant organisms was 15%. Compared with the pre-implementation period, the post-implementation period was associated with shorter median time from blood culture positivity to gram stain (7.4 vs 1.2 h), first genus level identification (7.2 vs 5.8 h) and first antimicrobial susceptibility result (24.1 vs 7.9 h). Similarly, the median time from blood culture positivity to clinicians first being informed was significantly shorter (9.2 vs 1.3 h). After removal of likely contaminants, 78% of patients were on effective empiric antimicrobials and for patients on ineffective empiric antimicrobials, effective therapy was initiated a median of 3.2 h sooner during the post-implementation period, without impact on mortality. Implementation of an overnight laboratory service was associated with significantly faster TAT for reporting blood culture results and more prompt initiation of effective antimicrobials for patients receiving ineffective empiric therapy, improving attainment of sepsis management goals.
Literature
1.
go back to reference De Waele JJ, Dhaese S (2019) Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient. Expert Rev Anti-Infect Ther 17(2):89–97CrossRef De Waele JJ, Dhaese S (2019) Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient. Expert Rev Anti-Infect Ther 17(2):89–97CrossRef
2.
go back to reference Weinbren MJ, Collins M, Heathcote R, Umar M, Nisar M, Ainger C et al (2018) Optimization of the blood culture pathway: a template for improved sepsis management and diagnostic antimicrobial stewardship. J Hosp Infect 98(3):232–235CrossRef Weinbren MJ, Collins M, Heathcote R, Umar M, Nisar M, Ainger C et al (2018) Optimization of the blood culture pathway: a template for improved sepsis management and diagnostic antimicrobial stewardship. J Hosp Infect 98(3):232–235CrossRef
3.
go back to reference Moore JS, Koerner RJ (2015) In the era of the 24 h laboratory, does communicating Gram stain results from blood cultures flagging positive outside of conventional working hours alter patient management? J Clin Pathol 68(11):938–941CrossRef Moore JS, Koerner RJ (2015) In the era of the 24 h laboratory, does communicating Gram stain results from blood cultures flagging positive outside of conventional working hours alter patient management? J Clin Pathol 68(11):938–941CrossRef
4.
go back to reference Barenfanger J, Graham DR, Kolluri L, Sangwan G, Lawhorn J, Drake CA et al (2008) Decreased mortality associated with prompt Gram staining of blood cultures. Am J Clin Pathol 130(6):870–876CrossRef Barenfanger J, Graham DR, Kolluri L, Sangwan G, Lawhorn J, Drake CA et al (2008) Decreased mortality associated with prompt Gram staining of blood cultures. Am J Clin Pathol 130(6):870–876CrossRef
5.
go back to reference Meda M, Clayton J, Varghese R, Rangaiah J, Grundy C, Dashti F et al (2017) What are the critical steps in processing blood cultures? A prospective audit evaluating current practice of reporting blood cultures in a centralised laboratory serving secondary care hospitals. J Clin Pathol 70(4):361–366CrossRef Meda M, Clayton J, Varghese R, Rangaiah J, Grundy C, Dashti F et al (2017) What are the critical steps in processing blood cultures? A prospective audit evaluating current practice of reporting blood cultures in a centralised laboratory serving secondary care hospitals. J Clin Pathol 70(4):361–366CrossRef
6.
go back to reference Savinelli T, Parenteau S, Mermel LA (2004) What happens when automated blood culture instrument detect growth but there are no technologists in the microbiology laboratory? Diagn Microbiol Infect Dis 48(3):173–174CrossRef Savinelli T, Parenteau S, Mermel LA (2004) What happens when automated blood culture instrument detect growth but there are no technologists in the microbiology laboratory? Diagn Microbiol Infect Dis 48(3):173–174CrossRef
7.
go back to reference Fitzpatrick F, Turley M, Humphreys H, Smyth E (2004) An after-hours clinical liaison blood culture service--is it worth it? Clin Microbiol Infect 10(10):917–921CrossRef Fitzpatrick F, Turley M, Humphreys H, Smyth E (2004) An after-hours clinical liaison blood culture service--is it worth it? Clin Microbiol Infect 10(10):917–921CrossRef
8.
go back to reference Thomson RB Jr, McElvania E (2018) Blood culture results reporting: how fast is your laboratory and is faster better? J Clin Microbiol 56(12) Thomson RB Jr, McElvania E (2018) Blood culture results reporting: how fast is your laboratory and is faster better? J Clin Microbiol 56(12)
9.
go back to reference CLSI (2017) Performance standards for antimicrobial susceptibility testing. CLSI CLSI (2017) Performance standards for antimicrobial susceptibility testing. CLSI
10.
go back to reference Palladino S, Kay ID, Costa AM, Lambert EJ, Flexman JP (2003) Real-time PCR for the rapid detection of vanA and vanB genes. Diagn Microbiol Infect Dis 45(1):81–84CrossRef Palladino S, Kay ID, Costa AM, Lambert EJ, Flexman JP (2003) Real-time PCR for the rapid detection of vanA and vanB genes. Diagn Microbiol Infect Dis 45(1):81–84CrossRef
11.
go back to reference Morton B, Nagaraja S, Collins A, Pennington SH, Blakey JD (2015) A retrospective evaluation of critical care blood culture yield - do support services contribute to the “Weekend Effect”? PLoS One 10(10):e0141361CrossRef Morton B, Nagaraja S, Collins A, Pennington SH, Blakey JD (2015) A retrospective evaluation of critical care blood culture yield - do support services contribute to the “Weekend Effect”? PLoS One 10(10):e0141361CrossRef
12.
go back to reference Horton CD, Rawlins MDM, Manning L, Ingram PR (2019) Non-adherence to antimicrobial stewardship prospective audit and feedback advice: risk factors and clinical consequences. J Infect Chemother 25(6):485–488CrossRef Horton CD, Rawlins MDM, Manning L, Ingram PR (2019) Non-adherence to antimicrobial stewardship prospective audit and feedback advice: risk factors and clinical consequences. J Infect Chemother 25(6):485–488CrossRef
13.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281CrossRef Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281CrossRef
14.
go back to reference Fitzpatrick JM, Biswas JS, Edgeworth JD, Islam J, Jenkins N, Judge R et al (2016) Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals. Clin Microbiol Infect 22(3):244–251CrossRef Fitzpatrick JM, Biswas JS, Edgeworth JD, Islam J, Jenkins N, Judge R et al (2016) Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals. Clin Microbiol Infect 22(3):244–251CrossRef
15.
go back to reference Cunney RJ, McNamara EB, Alansari N, Loo B, Smyth EG (1997) The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia. J Clin Pathol 50(12):1010–1012CrossRef Cunney RJ, McNamara EB, Alansari N, Loo B, Smyth EG (1997) The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia. J Clin Pathol 50(12):1010–1012CrossRef
16.
go back to reference Cressman AM, MacFadden DR, Verma AA, Razak F, Daneman N (2018) Empiric antibiotic treatment thresholds for serious bacterial infections: a scenario-based survey study. Clin Infect Dis Cressman AM, MacFadden DR, Verma AA, Razak F, Daneman N (2018) Empiric antibiotic treatment thresholds for serious bacterial infections: a scenario-based survey study. Clin Infect Dis
17.
go back to reference Sintchenko V, Iredell JR, Gilbert GL, Coiera E (2001) What do physicians think about evidence-based antibiotic use in critical care? A survey of Australian intensivists and infectious disease practitioners. Intern Med J 31(8):462–469CrossRef Sintchenko V, Iredell JR, Gilbert GL, Coiera E (2001) What do physicians think about evidence-based antibiotic use in critical care? A survey of Australian intensivists and infectious disease practitioners. Intern Med J 31(8):462–469CrossRef
18.
go back to reference Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377CrossRef Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377CrossRef
19.
go back to reference Idelevich EA, Seifert H, Sundqvist M, Scudeller L, Amit S, Balode A et al (2019) Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey. Clin Microbiol Infect Idelevich EA, Seifert H, Sundqvist M, Scudeller L, Amit S, Balode A et al (2019) Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey. Clin Microbiol Infect
20.
go back to reference Eveillard M, Lemarie C, Cottin J, Hitoto H, Mahaza C, Kempf M et al (2010) Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory. Clin Microbiol Infect 16(8):1084–1089CrossRef Eveillard M, Lemarie C, Cottin J, Hitoto H, Mahaza C, Kempf M et al (2010) Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory. Clin Microbiol Infect 16(8):1084–1089CrossRef
21.
go back to reference Murdoch DA, Koerner RJ, Speirs GE, MacGowan AP, Reeves DS (1995) Do blood cultures need continuous monitoring so that clinical action can be taken outside normal working hours? J Clin Pathol 48(11):1067–1068CrossRef Murdoch DA, Koerner RJ, Speirs GE, MacGowan AP, Reeves DS (1995) Do blood cultures need continuous monitoring so that clinical action can be taken outside normal working hours? J Clin Pathol 48(11):1067–1068CrossRef
22.
go back to reference Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA et al (2016) Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 29(1):59–103CrossRef Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA et al (2016) Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 29(1):59–103CrossRef
23.
go back to reference Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244CrossRef Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244CrossRef
24.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589–1596CrossRef Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589–1596CrossRef
25.
go back to reference Loots FJ, Smits M, van Steensel C, Giesen P, Hopstaken RM, van Zanten ARH (2018) Management of sepsis in out-of-hours primary care: a retrospective study of patients admitted to the intensive care unit. BMJ Open 8(9):e022832CrossRef Loots FJ, Smits M, van Steensel C, Giesen P, Hopstaken RM, van Zanten ARH (2018) Management of sepsis in out-of-hours primary care: a retrospective study of patients admitted to the intensive care unit. BMJ Open 8(9):e022832CrossRef
26.
go back to reference Culbreath K, Petti CA (2015) Balancing enthusiasm for innovative technologies with optimizing value: an approach to adopt new laboratory tests for infectious diseases using bloodstream infections as exemplar. Open Forum Infect Dis 2(2):ofv075CrossRef Culbreath K, Petti CA (2015) Balancing enthusiasm for innovative technologies with optimizing value: an approach to adopt new laboratory tests for infectious diseases using bloodstream infections as exemplar. Open Forum Infect Dis 2(2):ofv075CrossRef
27.
go back to reference Eby JC, Richey MM, Platts-Mills JA, Mathers AJ, Novicoff WM, Cox HL (2018) A healthcare improvement intervention combining nucleic acid microarray testing with direct physician response for management of Staphylococcus aureus bacteremia. Clin Infect Dis 66(1):64–71CrossRef Eby JC, Richey MM, Platts-Mills JA, Mathers AJ, Novicoff WM, Cox HL (2018) A healthcare improvement intervention combining nucleic acid microarray testing with direct physician response for management of Staphylococcus aureus bacteremia. Clin Infect Dis 66(1):64–71CrossRef
28.
go back to reference Van den Poel B, Klak A, Desmet S, Verhaegen J (2018) How small modifications in laboratory workflow of blood cultures can have a significant impact on time to results. Eur J Clin Microbiol Infect Dis 37(9):1753–1760CrossRef Van den Poel B, Klak A, Desmet S, Verhaegen J (2018) How small modifications in laboratory workflow of blood cultures can have a significant impact on time to results. Eur J Clin Microbiol Infect Dis 37(9):1753–1760CrossRef
29.
go back to reference Doern GV, Scott DR, Rashad AL (1982) Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates. Antimicrob Agents Chemother 21(6):1023–1024CrossRef Doern GV, Scott DR, Rashad AL (1982) Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates. Antimicrob Agents Chemother 21(6):1023–1024CrossRef
30.
go back to reference De Socio GV, Di Donato F, Paggi R, Gabrielli C, Belati A, Rizza G et al (2018) Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection. Eur J Clin Microbiol Infect Dis 37(12):2313–2322CrossRef De Socio GV, Di Donato F, Paggi R, Gabrielli C, Belati A, Rizza G et al (2018) Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection. Eur J Clin Microbiol Infect Dis 37(12):2313–2322CrossRef
31.
go back to reference She RC, Alrabaa S, Lee SH, Norvell M, Wilson A, Petti CA (2015) Survey of physicians’ perspectives and knowledge about diagnostic tests for bloodstream infections. PLoS One 10(3):e0121493CrossRef She RC, Alrabaa S, Lee SH, Norvell M, Wilson A, Petti CA (2015) Survey of physicians’ perspectives and knowledge about diagnostic tests for bloodstream infections. PLoS One 10(3):e0121493CrossRef
32.
go back to reference Tabak YP, Vankeepuram L, Ye G, Jeffers K, Gupta V, Murray PR (2018) Blood culture turnaround time in U.S. acute care hospitals and implications for laboratory process optimization. J Clin Microbiol 56(12) Tabak YP, Vankeepuram L, Ye G, Jeffers K, Gupta V, Murray PR (2018) Blood culture turnaround time in U.S. acute care hospitals and implications for laboratory process optimization. J Clin Microbiol 56(12)
Metadata
Title
Laboratory and clinical impacts of an overnight laboratory service
Authors
Paul R. Ingram
L. Barrett
E. Raby
P. Boan
G. A. Weaire-Buchanan
H. Darragh
P. Lloyd
I. Kay
J. Flexman
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03737-2

Other articles of this Issue 2/2021

European Journal of Clinical Microbiology & Infectious Diseases 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.